Pharmacokinetic evaluation of the combination of zidovudine and didanosine in children with human immunodeficiency virus infection
- 31 July 1994
- journal article
- clinical trial
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 125 (1), 142-146
- https://doi.org/10.1016/s0022-3476(94)70141-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- High-level resistance to zidovudine but not to zalcitabine or didanosine in human immunodeficiency virus from children receiving antiretroviral therapyThe Journal of Pediatrics, 1993
- Population Pharmacokinetic Analysis of Didanosine (2′,3′‐Dideoxyinosine) Plasma Concentrations Obtained in Phase I Clinical Trials in Patients with AIDS or AIDS‐Related ComplexThe Journal of Clinical Pharmacology, 1992
- Clinical Pharmacology of 2',3'-Dideoxyinosine in Human Immunodeficiency Virus-Infected ChildrenThe Journal of Infectious Diseases, 1992
- Resistance to ddI and Sensitivity to AZT Induced by a Mutation in HIV-1 Reverse TranscriptaseScience, 1991
- A Multicenter Trial of Oral Zidovudine in Children with Advanced Human Immunodeficiency Virus DiseaseNew England Journal of Medicine, 1991
- Dideoxyinosine in Children with Symptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1991
- Molecular Targets for AIDS TherapyScience, 1990
- Pharmacokinetics of zidovudine administered intravenously and orally in children with human immunodeficiency virus infectionThe Journal of Pediatrics, 1989
- Effect of Continuous Intravenous Infusion of Zidovudine (AZT) in Children with Symptomatic HIV InfectionNew England Journal of Medicine, 1988
- Preformulation solubility and kinetic studies of 2',3'-dideoxypurine nucleosides: potential anti-AIDS agentsInternational Journal of Pharmaceutics, 1988